Drugs for Urinary Incontinence and Overactive Bladder: Global Markets to 2022

Apr 2018| PHM199A| BCC Publishing

Report Highlights

The global drugs for urinary incontinence and overactive bladder market should reach $4.2 billion by 2022 from $3.6 billion in 2017 at a compound annual growth rate (CAGR) of 2.9%, from 2017 to 2022.

Report Includes

  • 96 data tables.
  • Country specific data and analysis for China, India, Japan, Australia, United Kingdom, Germany, France, Italy, Spain, Russia, USA, and Brazil
  • Coverage of types of urinary incontinence such as urge incontinence (UUI), stress incontinence (SUI), overflow incontinence (OUI), functional incontinence (FUI), and mixed symptoms (MUI)
  • Identification of effective treatment options for incontinence and overactive bladder
  • Analyses of Idiopathic bladder overactivity and neurogenic bladder overactivity and their probable causes
  • Detailed profiles of key competitors of the market, including Astellas Pharma Inc., Pfizer, Inc., Allergan, PLC., Merck & Co., Mylan N.V., Teva Pharmaceutical Industries Limited and Ferring Pharmaceuticals A/S

Report Scope

This research report categorizes the drugs for urinary incontinence and overactive bladder by type. Product type include idiopathic bladder overactivity, and neurogenic bladder overactivity.

Analyst Credentials

BCC Research analysts craft reference reports with a unique end noted referencing methodology, which allows users to cross reference and trace market numbers back to their source. These individuals are experts in secondary research and primary forecasting - compiling and layering existing data with their original research and analysis. The team has decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies

Latest reports include:

    Table of Contents & Pricing

    All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
    Title/Chapter Name Pages Price Member Price
    Full Report: Drugs for Urinary Incontinence and Overactive Bladder: Global Markets to 2022 179 $2,750 Free
    Chapter- 1: Introduction5Free
    Chapter- 2: Summary and Highlights2$250Free
    Chapter- 3: Drugs for Urinary Incontinence and Overactive Bladder Market Characteristics3$47Free
    Chapter- 4: Drugs for Urinary Incontinence and Overactive Bladder Market Size and Growth6$94Free
    Chapter- 5: Drugs for Urinary Incontinence and Overactive Bladder Market Trends and Strategies2$31Free
    Chapter- 6: PESTLE Analysis4$63Free
    Chapter- 7: Drugs for Urinary Incontinence and Overactive Bladder Market Segmentation6$94Free
    Chapter- 8: Drugs for Urinary Incontinence and Overactive Bladder Market: Regional and Country Analyses10$157Free
    Chapter- 9: Drugs for Urinary Incontinence and Overactive Bladder Market Customer Information2$31Free
    Chapter- 10: Global Drugs for Urinary Incontinence and Overactive Bladder Market Comparison with Macro Economic Factors2$31Free
    Chapter- 11: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market9$141Free
    Chapter- 12: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market: Country Analysis24$377Free
    Chapter- 13: Western Europe Drugs for Urinary Incontinence and Overactive Bladder Market8$126Free
    Chapter- 14: UK Drugs for Urinary Incontinence and Overactive Bladder Market: Country Analysis25$393Free
    Chapter- 15: Eastern Europe Drugs for Urinary Incontinence and Overactive Bladder Market8$126Free
    Chapter- 16: Eastern Europe Drugs for Urinary Incontinence and Overactive Bladder Market: Country Analysis5$79Free
    Chapter- 17: North America Drugs for Urinary Incontinence and Overactive Bladder Market8$126Free
    Chapter- 18: North America Drugs for Urinary Incontinence and Overactive Bladder Market: Country Analysis5$79Free
    Chapter- 19: South America Drugs for Urinary Incontinence and Overactive Bladder Market8$126Free
    Chapter- 20: South America Drugs for Urinary Incontinence and Overactive Bladder Market: Country Analysis5$79Free
    Chapter- 21: Middle East Drugs for Urinary Incontinence and Overactive Bladder Market8$126Free
    Chapter- 22: Africa Drugs for Urinary Incontinence and Overactive Bladder Market8$126Free
    Chapter- 23: Drugs for Urinary Incontinence and Overactive Bladder Market: Competitive Landscape11$173Free
    Chapter- 24: Key Mergers and Acquisitions in the Drugs for Urinary Incontinence and Overactive Bladder Market1$16Free
    Chapter- 25: Appendix3$47Free
    Why BCC Research?

    Every purchase provides access to:

    • Thousands of recently published reports from select publishers
    • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
    • Our analysts and research concierge for all inquiries
    CUSTOM RESEARCH

    Need a custom data table, graph or complete report? Tell us more.

    Contact Us
    RELATED REPORTS
    Share This Report